Treatment of antidepressant-induced sexual dysfunction

Hospital Practice

Volumn 34, Issue 1, 1999, Pages 89-96

  Moore, Brian E ^a,b   Rothschild, Anthony J ^a,b  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; AMANTADINE; AMFEBUTAMONE; ANTIANDROGEN; ANTIDOTE; ANTIHYPERTENSIVE AGENT; ANXIOLYTIC AGENT; BUSPIRONE; CANNABIS; CENTRAL DEPRESSANT AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLONIDINE; CYPROHEPTADINE; DEXAMPHETAMINE; DIAMORPHINE; FLUOXETINE; HISTAMINE H2 RECEPTOR ANTAGONIST; METHADONE; MONOAMINE OXIDASE INHIBITOR; NEFAZODONE; NEUROLEPTIC AGENT; PAROXETINE; PEMOLINE; SEDATIVE AGENT; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; SPIRONOLACTONE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; YOHIMBINE;

DEPRESSION; DOSE RESPONSE; DRUG MECHANISM; HUMAN; NAUSEA; OBSESSION; PANIC; REVIEW; SEXUAL DYSFUNCTION; TOBACCO; XEROSTOMIA;

EID: 0033556103     PISSN: 87502836     EISSN: None     Source Type: Journal    
DOI: 10.3810/hp.1999.01.127     Document Type: Review

References (15)

1. Ashton AK, Hamer R, Rosen RC: Serotonin reuptake inhibitor-induced sexual dysfunction and its treatment: A large-scale retrospective study of 596 psychiatric outpatients. J Sex Marital Ther 23:165, 1997
2. Ashton AK, Rosen RC: Bupropion as an antidote for serotonin reuptake inhibitor-induced sexual function. J Clin Psychiatry 59:112, 1998
3. Bartlik B, Kaplan P, Kaplan HS: Psychostimulants apparently reverse sexual dysfunction secondary to selective serotonin reuptake inhibitors. J Sex Marital Ther 21:264, 1995
4. Feiger A et al: Nefazodone versus sertraline in outpatients with major depression: Focus on efficacy, tolerability, and effects on sexual functions and satisfaction. J Clin Psychiatry 57(Suppl 2):53, 1996
5. Gitlin MJ: Psychotropic medications and their effects on sexual function: Diagnosis, biology, and treatment approaches. J Clin Psychiatry 55:406, 1994
6. Gitlin MJ: Treatment of sexual side effects with dopaminergic agents (Letter). J Clin Psychiatry 56:124, 1995
7. Kavoussi RJ et al: Double-blind comparison of bupropion sustained release and sertraline in depressed outpatients. J Clin Psychiatry 58:532, 1997
8. Kupfer DJ et al: Five-year outcome for maintenance therapies in recurrent depression. Arch Gen Psychiatry 49:769, 1992
9. Labbate LA et al: Sexual dysfunction induced by serotonin reuptake antidepressants. J Sex Marital Ther 24:3, 1998
10. Montejo-Gonzalez AL et al: SSRI-lnduced sexual dysfunction: Fluoxetine, paroxetine, sertraline, and fluvoxamine In a prospective, multicenter, and descriptive clinical study of 344 patients. J Sex Martial Ther 23:176, 1997
11. Norden MJ: Buspirone treatment of sexual dysfunction associated with selective serotonin reuptake inhibitors. Depression 2:109, 1994
12. Reimherr FW et al: Antidepressant efficacy of sertraline: A double-blind, placebo-, amitriptyline-controlled multicenter comparison study in outpatients with major depression. J Clin Psychiatry 51(12 suppl B):18, 1990
13. Rothschild AJ: Selective serotonin reuptake inhibitor-induced sexual dysfunction: Efficacy of a drug holiday. Am J Psychiatry 152:1514, 1995
14. Segraves RT: Antidepressant-induced sexual dysfunction. J Clin Psychiatry 59:48, 1998
15. Shrivastava RK et al: Amantadine in the treatment of sexual dysfunction associated with selective serotonin reuptake inhibitors. J Clin Psychopharmacol 15:83, 1995